The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation
- 16 February 2010
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 152 (4) , 265
- https://doi.org/10.7326/0003-4819-152-4-201002160-00018
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Should Patient Characteristics Influence Target Anticoagulation Intensity for Stroke Prevention in Nonvalvular Atrial Fibrillation?Circulation: Cardiovascular Quality and Outcomes, 2009
- Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic RangeCirculation, 2008
- Faculty Opinions recommendation of Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.Published by H1 Connect ,2008
- Comparison of Risk Stratification Schemes to Predict Thromboembolism in People With Nonvalvular Atrial FibrillationJournal of the American College of Cardiology, 2008
- Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trialThe Lancet, 2007